Skip to content
10-K

Annual Report

XERIS PHARMACEUTICALS INC

0001346302-21-000026

← back to feed
Filed
Mar 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 28, 2021 59.76M sh
Capex FY 2020 · Dec 31, 2020 −$377K
Capex FY 2020 · Dec 31, 2019 −$1.11M
Operating Cash Flow FY 2020 · Dec 31, 2020 −$80.56M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$104.35M
Short Term Investments FY 2020 · Dec 31, 2020 $96.19M
Short Term Investments FY 2020 · Dec 31, 2019 $56.03M
Cash And Equivalents FY 2020 · Dec 31, 2020 $37.6M
Cash And Equivalents FY 2020 · Dec 31, 2019 $19.52M
Cash And Equivalents FY 2020 · Dec 31, 2018 $45.72M
Stockholders Equity FY 2020 · Dec 31, 2020 $33.76M
Stockholders Equity FY 2020 · Dec 31, 2019 $14.44M
Stockholders Equity FY 2020 · Dec 31, 2018 $75.41M
Current Liabilities FY 2020 · Dec 31, 2020 $28.21M
Current Liabilities FY 2020 · Dec 31, 2019 $27.34M
Total Liabilities FY 2020 · Dec 31, 2020 $125.39M
Total Liabilities FY 2020 · Dec 31, 2019 $94.55M
Current Assets FY 2020 · Dec 31, 2020 $152.21M
Current Assets FY 2020 · Dec 31, 2019 $87.48M
Total Assets FY 2020 · Dec 31, 2020 $159.15M
Total Assets FY 2020 · Dec 31, 2019 $108.99M
Sga Expense FY 2020 · Dec 31, 2020 $73.73M
Sga Expense FY 2020 · Dec 31, 2019 $63.06M
Rd Expense FY 2020 · Dec 31, 2020 $20.92M
Rd Expense FY 2020 · Dec 31, 2019 $60.44M
Net Income FY 2020 · Dec 31, 2020 −$91.14M
Net Income FY 2020 · Dec 31, 2019 −$125.58M
Operating Income FY 2020 · Dec 31, 2020 −$83.55M
Operating Income FY 2020 · Dec 31, 2019 −$122.38M
Gross Profit FY 2020 · Dec 31, 2020 $11.11M
Gross Profit FY 2020 · Dec 31, 2019 $1.12M
Revenue FY 2020 · Dec 31, 2020 $20.16M
Revenue FY 2020 · Dec 31, 2019 $1.63M